Skip to main content
Erschienen in: Current Diabetes Reports 10/2022

19.08.2022 | Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Potential Clinical Applications for Continuous Ketone Monitoring in the Hospitalized Patient with Diabetes

verfasst von: Michelle Jaromy, Joshua D. Miller

Erschienen in: Current Diabetes Reports | Ausgabe 10/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this review, the authors discuss potential clinical applications for continuous ketone monitoring (CKM) in a broad continuum of clinical settings from pre-hospital care and the emergency department to acute inpatient management and post-discharge follow-up.

Recent Findings

Though in its early stages, the concept of a novel continuous ketone sensing technology exerts great potential for use in the detection and hospital management of DKA, namely to overcome diagnostic barriers associated with ketoacidosis in patients with diabetes and obtain real-time BOHB levels, which may be useful in understanding both patients’ response to treatment and DKA trajectory. Peri- and intra-operative use of CKM technology can potentially be applied in a number of urgent and elective surgical procedures frequently underwent by patients with diabetes and in the observation of patients during peri-operative fasting. In transitional care management, CKM technology could potentially facilitate patients’ safe transition through levels of care, following hospital discharge from a DKA episode.

Summary

This evaluation of the literature presents the potential advantages of adopting CKM and integrating this technology into the care algorithm of patients at risk for ketoacidosis.
Literatur
22.
Zurück zum Zitat Vanelli M, Chiari G, Capuano C, Iovane B, Bernardini A, Giacalone T. The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab. 2003;16(5–6):312–6. PubMed Vanelli M, Chiari G, Capuano C, Iovane B, Bernardini A, Giacalone T. The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab. 2003;16(5–6):312–6. PubMed
23.
Zurück zum Zitat Vanelli M, Mastrorilli C, Fainardi V, et al. Clinical utility of beta-hydroxybutyrate measurement in the management of physiological ketosis at home in children under 5. Acta Biomed. 2019;90(2):215–20 (Published 2019 May 23). PubMed Vanelli M, Mastrorilli C, Fainardi V, et al. Clinical utility of beta-hydroxybutyrate measurement in the management of physiological ketosis at home in children under 5. Acta Biomed. 2019;90(2):215–20 (Published 2019 May 23). PubMed
Metadaten
Titel
Potential Clinical Applications for Continuous Ketone Monitoring in the Hospitalized Patient with Diabetes
verfasst von
Michelle Jaromy
Joshua D. Miller
Publikationsdatum
19.08.2022
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 10/2022
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-022-01489-6

Weitere Artikel der Ausgabe 10/2022

Current Diabetes Reports 10/2022 Zur Ausgabe

Pathogenesis of Type 2 Diabetes and Insulin Resistance (M-E Patti, Section Editor)

Growth Hormone and Counterregulation in the Pathogenesis of Diabetes

Psychosocial Aspects (J Pierce, Section Editor)

Social Care Recommendations in National Diabetes Treatment Guidelines

Update Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.